Attached files

file filename
EX-10.7 - AMENDMENT TO SERIES C PREFERRED STOCK SECURITIES PURCHASE AGREEMENT - Icagen, Inc.f10q0918ex10-7_icagen.htm
EX-32.2 - CERTIFICATION - Icagen, Inc.f10q0918ex32-2_icagen.htm
EX-32.1 - CERTIFICATION - Icagen, Inc.f10q0918ex32-1_icagen.htm
EX-31.2 - CERTIFICATION - Icagen, Inc.f10q0918ex31-2_icagen.htm
EX-31.1 - CERTIFICATION - Icagen, Inc.f10q0918ex31-1_icagen.htm
EX-10.8 - SERIES C PREFERRED STOCK SUBORDINATION AGREEMENT - Icagen, Inc.f10q0918ex10-8_icagen.htm
10-Q - QUARTERLY REPORT - Icagen, Inc.f10q0918_icageninc.htm

Exhibit 4.6

 

THIS PROMISSORY NOTE AMENDS, RESTATES AND REPLACES THE PROMISSORY NOTE ISSUED AUGUST 13, 2018, WHICH IS NULL AND VOID. THIS PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, ASSIGNED OR OTHERWISE DISPOSED OF, AND NO TRANSFER OF THIS PROMISSORY NOTE WILL BE MADE BY THE COMPANY OR ITS TRANSFER AGENT IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 

FORM OF AMENDED AND RESTATED 10% SUBORDINATED PROMISSORY NOTE

 

 

$_________ Durham, North Carolina
  August    , 2018 (the “Issue Date”)

 

FOR VALUE RECEIVED, Icagen, Inc., a Delaware corporation (the “Company”), with its principal place of business at 4222 Emperor Boulevard, Suite 350, Research Triangle Park, Durham, North Carolina 27703, its successors and assigns (the “Company”), promises to pay to the order of ________________________ (“Payee”), having an address at _____________________, the principal sum of _____________________ Dollars ($_________) on the earlier of (i) the date that is twelve (12) months after the Issue Date or (ii) the Company’s receipt of the proceeds of funding from its next collaboration/ partnership (the “Maturity Date”), together with interest on the principal amount hereof at the rate of 10% per annum, payable on the Maturity Date, commencing on the Issue Date. Payments on both principal and interest are to be made in lawful money of the United States of America unless Payee agrees to another form of payment.

 

1. This Note is one of a series of a maximum of One Million Five Hundred Thousand Dollars ($1,500,000) of notes being issued by and among the Company and certain note investors (the “Investors”) as part of a bridge financing. This Note and all obligations hereunder, and the other Notes issued as part of this series to the Investors and all obligations thereunder, respectively, shall rank pari passu with each other. NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, THIS NOTE SHALL BE SUBORDINATED IN RIGHT OF PAYMENT IN ALL RESPECTS TO (A) THAT CERTAIN CREDIT AGREEMENT AND GUARANTY, DATED AS OF AUGUST , 2018, AMONG THE COMPANY, AS BORROWER, THE GUARANTORS PARTY THERETO, THE LENDERS FROM TIME TO TIME PARTY THERETO AND PERCEPTIVE CREDIT HOLDINGS II, LP (“PERCEPTIVE”), AS ADMINISTRATIVE AGENT AND (B) THAT CERTAIN CREDIT AGREEMENT AND GUARANTY, DATED AS OF AUGUST , 2018, AMONG ICAGEN-T, INC., A DELAWARE CORPORATION, AS BORROWER, THE COMPANY, AS GUARANTOR, THE OTHER GUARANTORS PARTY THERETO, THE LENDERS FROM TIME TO TIME PARTY THERETO AND PERCEPTIVE, AS ADMINISTRATIVE AGENT (COLLECTIVELY, AS SUCH CREDIT AGREEMENTS MAY BE MODIFIED, AMENDED OR RESTATED IN THEIR ENTIRETY OR OTHERWISE FROM TIME TO TIME, THE “CREDIT AGREEMENTS”). IF ANY PAYMENT IN ANY FORM WITH RESPECT TO THIS NOTE IS COLLECTED OR RECEIVED BY ANY INVESTOR AFTER AN “EVENT OF DEFAULT” (AS DEFINED IN ANY CREDIT AGREEMENT) HAS OCCURRED AND IS CONTINUING, SUCH PAYMENT SHALL BE HELD BY SUCH INVESTOR IN TRUST FOR THE BENEFIT OF THE CREDITORS UNDER THE CREDIT AGREEMENTS AND SHALL FORTHWITH BE PAID OVER TO PERCEPTIVE, IN ITS CAPACITY AS ADMINISTRATIVE AGENT UNDER EACH CREDIT AGREEMENT, TO BE CREDITED AND APPLIED AGAINST THE OBLIGATIONS DUE TO THE CREDITORS UNDER SUCH CREDIT AGREEMENTS, BUT WITHOUT AFFECTING, IMPAIRING OR LIMITING IN ANY MANNER THE LIABILITY OF THE COMPANY UNDER ANY OTHER PROVISION OF THIS NOTE.

 

 

 

 

2. As used herein, a “Default” means a material default by the Company of this Note, the Note Purchase Agreement dated the date hereof between the Company and Payee, or the Pledge Agreement issued by the Company to Payee on the date hereof. Amounts not paid when due hereunder shall bear interest from the due date until such amounts are paid at the rate of one percent (1%) per month; provided, however, that in the event such interest rate would violate any applicable usury law, the default rate shall be the highest lawful interest rate permitted under such usury law. Upon the occurrence of a Default and receipt of written notice by the Company from Payee of such Default, the principal and interest due hereunder shall be immediately due and payable by the Company to Payee.

 

3. Presentment, demand, protest or notice of any kind are hereby waived by the Company. The Company may not set off against any amounts due to Payee hereunder any claims against Payee or other amounts owed by Payee to the Company.

 

4. All rights and remedies of Payee under this Note are cumulative and in addition to all other rights and remedies available at law or in equity, and all such rights and remedies may be exercised singly, successively and/or concurrently. Failure to exercise any right or remedy shall not be deemed a waiver of such right or remedy.

 

5. The Company agrees to pay all reasonable costs of collection, including attorneys' fees which may be incurred in the collection of this Note or any portion thereof and, in case an action is instituted for such purposes, the amount of all attorneys' fees shall be such amount as the court shall adjudge reasonable.

 

6. This Note is made and delivered in, and shall be governed, construed and enforced under the laws of the State of New York.

 

7. This Note shall be subject to prepayment, at the option of the Company, in whole or in part, at any time and from time to time, without premium or penalty.

 

8. This Note or any benefits or obligations hereunder may not be assigned or transferred by the Company.

 

  ICAGEN, INC.
     
  By:    
  Name:  Richard Cunningham
  Title: Chief Executive Officer

 

Acknowledged and Agreed:

 

By:    
Name:                                        
Title: